From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q3 2022 call → NOWe need answer YES/NO. Need analyze transcript. Question asks whether management describes recently crossed into approved/specified/listed/qualified etc inside buyers' systems so future business can arrive without discrete selling event, and conveys new enough that most volume ahead. Look at transcript. Management discusses various partnerships: T-Mobile offering Ooma Telo to their wireless home internet customers. Is that a gateway? T-Mobile will offer Ooma Telo to customers. That could be a distribution channel where T-Mobile presents it. Is it "approved, specified, listed, qualified" inside buyer's purchasing system? T-Mobile will offer Ooma Telo to their customers. That is a retail/distribution arrangement, but is it a routine pathway? It might be a new channel. But question asks "recently crossed from candidate to approved/specified/listed..." Management says "T-Mobile will soon offer Ooma Telo to their wireless home internet customers." That is a new distribution partnership. Does it mean future business can arrive without discrete selling event? T-Mobile will offer it; customers choose. It is a standard retail offering, not necessarily a procurement system. Also "we are planning to make it available in first half of next year" for Pro plus. AirDial introduced, strong interest but not yet approved. Largest customer rollout: "we are now quite close to executing our full plan" and "first half of next year will be quite significant" - but that's a customer relationship, not a gateway. Also "we increased number of agents and resellers" - ordinary selling relationships. Need identify if management describes a specific buyer-side system where company is now included. The T-Mobile partnership: T-Mobile will offer Ooma Telo to their customers. That is a distribution channel, but is it a "program" where Ooma is a listed option? It could be considered a program: T-Mobile's home internet customers can get Ooma Telo. But is it "approved, specified, listed, qualified" inside buyers' purchasing? It's a retail offer. The question says "ordinary selling relationships, routine reseller/distribution agreements" are NO. This seems like a routine reseller/distribution agreement. Also management doesn't say it's new enough that most volume ahead? They say "we will know more next call" and "we are launching soon" - so it's new.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.